FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
6.89
-0.03 (-0.43%)
Aug 1, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Novel Therapeutics
147.75M
Log In
Log In
Log In
Log In
Upgrade
Novel Therapeutics Growth
4.99%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
China
109.38M
Log In
Log In
Log In
Log In
Upgrade
China Growth
29.24%
Log In
Log In
Log In
Log In
Upgrade
Japan
15.87M
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
62.51%
Log In
Log In
Log In
Log In
Upgrade
United States
12.96M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
3.53%
Log In
Log In
Log In
Log In
Upgrade
Europe
9.55M
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
-71.77%
Log In
Log In
Log In
Log In
Upgrade
Foreign
-
Log In
Log In
Log In
Log In
Upgrade
Foreign Growth
-
Log In
Log In
Log In
Log In
Upgrade